Due to necessary maintenance, Xenbase will be unavailable December 24-30, 2014. We apologize for the inconvenience.

Click on this message to dismiss it.
Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-37264
Nat Chem Biol. February 1, 2008; 4 (2): 119-25.

A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex.

Dupré A , Boyer-Chatenet L , Sattler RM , Modi AP , Lee JH , Nicolette ML , Kopelovich L , Jasin M , Baer R , Paull TT , Gautier J .


Abstract
The MRN (Mre11-Rad50-Nbs1)-ATM (ataxia-telangiectasia mutated) pathway is essential for sensing and signaling from DNA double-strand breaks. The MRN complex acts as a DNA damage sensor, maintains genome stability during DNA replication, promotes homology-dependent DNA repair and activates ATM. MRN is essential for cell viability, which has limited functional studies of the complex. Small-molecule inhibitors of MRN could circumvent this experimental limitation and could also be used as cellular radio- and chemosensitization compounds. Using cell-free systems that recapitulate faithfully the MRN-ATM signaling pathway, we designed a forward chemical genetic screen to identify inhibitors of the pathway, and we isolated 6-(4-hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (mirin, 1) as an inhibitor of MRN. Mirin prevents MRN-dependent activation of ATM without affecting ATM protein kinase activity, and it inhibits Mre11-associated exonuclease activity. Consistent with its ability to target the MRN complex, mirin abolishes the G2/M checkpoint and homology-dependent repair in mammalian cells.

PubMed ID: 18176557
PMC ID: PMC3065498
Article link: Nat Chem Biol.
Grant support: CA92245 NCI NIH HHS , CA92245 NCI NIH HHS , CA92245 NCI NIH HHS , CA92245 NCI NIH HHS , CA92245 NCI NIH HHS , CA92245 NCI NIH HHS , CA95866 NCI NIH HHS , CA95866 NCI NIH HHS , CA95866 NCI NIH HHS , CA95866 NCI NIH HHS , CA95866 NCI NIH HHS , CA95866 NCI NIH HHS , CA97403 NCI NIH HHS , CA97403 NCI NIH HHS , CA97403 NCI NIH HHS , CA97403 NCI NIH HHS , CA97403 NCI NIH HHS , CA97403 NCI NIH HHS , GM54668 NIGMS NIH HHS , R01 CA092245-06 NCI NIH HHS , R01 CA092245-06 NCI NIH HHS , R01 CA092245-06 NCI NIH HHS , R01 CA092245-06 NCI NIH HHS , R01 CA092245-06 NCI NIH HHS , R01 CA092245-06 NCI NIH HHS , R01 GM054668-11 NIGMS NIH HHS , P01 CA097403 NCI NIH HHS , P01 CA097403 NCI NIH HHS , P01 CA097403 NCI NIH HHS , P01 CA097403 NCI NIH HHS , P01 CA097403 NCI NIH HHS , P01 CA097403 NCI NIH HHS , R01 CA092245 NCI NIH HHS , R01 CA092245 NCI NIH HHS , R01 CA092245 NCI NIH HHS , R01 CA092245 NCI NIH HHS , R01 CA092245 NCI NIH HHS , R01 CA092245 NCI NIH HHS , R01 GM054668 NIGMS NIH HHS

Genes referenced: atm mre11a nbn rad50
Antibodies referenced:
Morpholinos referenced:

My Xenbase: [ Log-in / Register ]
version: [3.3.1]


Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556